SPEXIN-BASED GARANIN TYPE 2 RECEPTOR AGONIST AND USE THEREOF

• 收藏
• 分享

专利权人:

ニューラクル サイエンス カンパニー リミテッド

发明人:

ソン，ジェヨン,ファン，ジョンイク,キム，ドンフン,ソン，ギフン,イ，ユナ,ユン，ソンシク,レイエス－アルカラス，アルファクシャド

申请号：

JP2018523789

公开号：

JP6619097B2

申请日:

2016.11.30

申请国别(地区):

JP

年份:

2019

代理人:

摘要：

The present invention relates to spexin-based agonists specific for galanin receptor type 2 and use thereof. More specifically, the present invention provides peptide-based agonists with high specificity for galanin receptor type 2 and improved stability. The peptide-based agonists are involved in the regulation of in vivo physiological functions, such as food intake, anxiety, emotion, and addiction, for which galanin receptors type 2 is responsible, to effectively suppress appetite, help recover from anxiety disorder, and reduce pleasure addiction. Therefore, the peptide-based agonists can be used to prevent or treat galanin receptor type 2-mediated diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/